q29 pls provide Complete solution. thankyou so much.

Question 29 1 pts An entity owns a pharmaceutical business with a year-end of September 30, 2020. The company commenced the development stage of a new drug on January 1, 2020. P40,000 per month was incurred until the project was completed on June 30, 2020, when the drug went into immediate production. The directors became confident of the project's success on March 1, 2020. The drug has an estimated life span of five years and time-apportionment is used by the company where applicable. What amount is charged to profit or loss for development costs, including any amortization for the year ended September 30, 2020? O 240,000 88,000 O 80.000 O 360.000 Previous Next